Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
1 विचारों
administrator
07/29/23
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली